Montauk Renewables specializes in capturing methane from landfills and agricultural sources and converting it into renewable natural gas (RNG) and electricity. Because most of its revenue depends on the sale of environmental credits known as RINs under the U.S. Renewable Fuel Standard, results are highly sensitive to commodity and credit prices. The company has been navigating a period of RIN-price pressure and shifting contract mix, which has made quarterly earnings increasingly volatile. With the third-quarter report now delayed, investors are seeking clarity on production trends, cost control, and whether management's lowered full-year guidance remains intact. The outcome will shape expectations for the company's growth projects and its ability to sustain profitability. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Analysts expect MNTK to post earnings per share of approximately $0.05 on revenue of about $55 million for the third quarter of 2026. That revenue estimate represents a meaningful increase from the $45.3 million reported in the third quarter of 2025, a period when EPS of $0.04 exceeded consensus. For context, the company delivered second-quarter 2026 revenue of $54.0 million, above the roughly $49.7 million consensus, while EPS landed at $0.00 against a $0.02 estimate. Investors will also focus on non-GAAP adjusted EBITDA, RNG production measured in MMBtu, and average realized RIN prices. In August, management lowered its fiscal 2026 revenue outlook to a range of $198 million to $216 million, down from a prior $210 million to $231 million, so any revision to that guidance will be closely scrutinized.
Sentiment heading into the quarter is cautious. The decision to reschedule the earnings release and extend the Form 10-Q filing deadline has introduced an element of uncertainty, and investors will be watching for any explanation alongside the eventual results. The stock has experienced elevated volatility around prior reports, with sharp moves tied to RIN prices and guidance updates. Key risk factors include further declines in environmental-credit prices, higher operating and maintenance costs, and the pace at which new projects ramp up production. A stronger-than-expected RIN-price environment or improved production volumes could support a more constructive reaction, while another guidance reduction would likely weigh on shares.
Following the third-quarter release, investors should focus on several forward-looking signals. First, any update to the company's full-year 2026 revenue and production guidance will be important, particularly after the August reduction to a $198 million to $216 million revenue range. Management has separately guided RNG revenues of $175 million to $190 million and RNG production of 5.8 to 6.0 million MMBtu for the year. Second, the trajectory of RIN prices and the mix of fixed-price versus market-based contracts will continue to drive margins. Montauk has shifted more production toward fixed/floor-price arrangements, which provide stability but can limit upside when credit prices rise. Third, the ramp-up of newer projects, including the Montauk Ag Renewables facility commissioned in 2026, will be a key catalyst for production growth. Finally, regulatory developments from the Environmental Protection Agency around renewable fuel volume standards can materially influence the value of the company's environmental attributes. Balancing these factors will be central to assessing the company's earnings trajectory in the quarters ahead. From what I see, this is important because it ties directly into long-term project viability.
In preparing this review, I turned to Tickeron’s AI Screener to cross-check comparable names in the renewable sector and refine my view on relative positioning. The tool’s customizable filters for fundamentals, technical patterns, and performance metrics helped surface additional context without manual effort. It has become a regular part of how I evaluate opportunities like this one, especially when timing and sector dynamics are in flux.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MNTK moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 42 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on MNTK as a result. In 75 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for MNTK just turned positive on November 02, 2026. Looking at past instances where MNTK's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.
The 10-day moving average for MNTK crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +10.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTK advanced for three days, in 222 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 155 of 176 cases where MNTK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
MNTK broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. MNTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.464) is normal, around the industry mean (2.284). P/E Ratio (54.400) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ChemicalsSpecialty